All
Nobler in the Mind? The Dilemma for European Research
May 1st 2003Europe's pharmaceutical R&D has recently come under a barrage of criticism. Nobel laureate, Kary Mullis, highlighted the issue of over-legislating biotechnology and the business industry expressed its dismay concerning the EU's overly cautious approach to any kind of development. Action is needed before the sector's future resembles the plot of a Shakespearean tragedy.
Awards for Hussain, DeLuca, Schwartz; AAPS Names Fellows
November 3rd 206AAPS, San Antonio (Oct. 29)-At the opening session of the annual meeting and exposition of the American Association of Pharmaceutical Scientists' AAPS President Jay Sisco presented ten achievement awards and 24 AAPS fellowships recognizing professional contributions to the pharmaceutical sciences.